Visium Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Visium Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,804,261	Closed	-$46.5M	–	549
2016 Q1	$46.5M	Sell	2,804,261 -156,672	-5%	-$2.74M	0.79%	25
2015 Q4	$64.2M	Buy	2,960,933 +1,171,919	+66%	+$22.8M	0.96%	16
2015 Q3	$35.5M	Buy	1,789,014 +105,314	+6%	+$3.33M	0.48%	38
2015 Q2	$58.5M	Sell	1,683,700 -1,276,846	-43%	-$39M	0.83%	19
2015 Q1	$76.9M	Sell	2,960,546 -1,531,978	-34%	-$28.1M	1.13%	11
2014 Q4	$57.9M	Buy	4,492,524 +201,552	+5%	+$2.52M	0.82%	19
2014 Q3	$52.7M	Buy	4,290,972 +1,824,909	+74%	+$21.2M	0.78%	18
2014 Q2	$39M	Buy	2,466,063 +228,063	+10%	+$3.26M	0.61%	24
2014 Q1	$33.8M	Buy	+2,238,000	New	+$25.3M	0.55%	33

Other funds holding HZNP

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Visium Asset Management's HZNP Position: Q2 2016 in Review

Visium Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2016, closing a stake of 2,804,261 shares — an estimated $46.5M sold.

Visium Asset Management first reported a position in HZNP in Q1 2014 and held it in 9 quarters. The position peaked at $76.9M in Q1 2015. 198 funds tracked by Wall St. Rank hold HZNP as of Q2 2016.

Visium Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 2,804,261 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2016, an estimated $46.5M.
Visium Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 9 quarters.
Visium Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $76.9M in Q1 2015.
198 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.